← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-4 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV14행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePhase 1
OH2 oncolytic virus (OH2 oncolytic virus)
Taizhou HoudeAoke Biomedical Co., …·Digestive System Neoplasms
14 trials
Overview
Program
OH2 oncolytic virus
Overview
Company
Taizhou HoudeAoke Biomedical Co., Ltd.
Overview
Modality
CGT
Overview
Target
Digestive System Neoplasms
Overview
Indication
Digestive System Neoplasms
Overview
Phase
PHASE_1
Overview
Status
ACTIVE
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Watch
Overview
Approval status
Investigational
Toxicology
Major finding
Targeting cancer stem cells predicts response and reverses chemoresistance in ascites-derived ovarian cancer organoids.. Ovarian cancer (OC) is frequently diagnosed at an advanced stage, where tumor heterogeneity and rapid development of chemoresistance contribute to a poor prognosis. The lack of reliable predictive biomarkers further hinders the development of effective treatment strategies. Pati…
Clinical
Safety signal
Targeting cancer stem cells predicts response and reverses chemoresistance in ascites-derived ovarian cancer organoids.. Ovarian cancer (OC) is frequently diagnosed at an advanced stage, where tumor heterogeneity and rapid development of chemoresistance contribute to a poor prognosis. The lack of reliable predictive biomarkers further hinders the development of effective treatment strategies. Pati…
Clinical
Program phase
PHASE_1